Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 43151-43200 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05521529
Cushing's Syndrome Before and After Treatment (CORRECT)
N/ARecruiting
20 participants
Started: Feb 16, 2023 · Completed: Nov 30, 2032
1 condition2 sponsors1 location
NCT05009797
PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation
N/ARecruiting
750 participants
Started: Feb 16, 2023 · Completed: Feb 28, 2031
1 condition1 sponsor1 location
NCT05746078
Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients with Mild to Moderate Facial Ptosis.
N/ARecruiting
99 participants
Started: Feb 16, 2023 · Completed: Mar 31, 2029
2 conditions2 sponsors3 locations
NCT05699785
Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual Therapy
NARecruiting
500 participants
Started: Feb 16, 2023 · Completed: Feb 1, 2026
1 condition1 sponsor2 locations
NCT06315140
Assessing and Addressing Community Exposures to Environmental Contaminants
NARecruiting
400 participants
Started: Feb 16, 2023 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT05608525
Upper Limb tDCS in Chronic Stroke Patients (NOURISH)
NARecruiting
51 participants
Started: Feb 16, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05817214
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
PHASE2Recruiting
35 participants
Started: Feb 16, 2023 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT05624190
Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization
PHASE4Recruiting
256 participants
Started: Feb 16, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT05872776
BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation
NARecruiting
50 participants
Started: Feb 16, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor2 locations
NCT05477797
Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.
NARecruiting
420 participants
Started: Feb 16, 2023 · Completed: Jan 15, 2026
3 conditions1 sponsor1 location
NCT05931419
High-Risk prostatE Cancer radiatiOn Versus surgERy
N/ARecruiting
837 participants
Started: Feb 16, 2023 · Completed: Jun 30, 2030
2 conditions1 sponsor29 locations
NCT06947512
Personalization of Visual Characters and Text-to-Speech (TTS) to Support Learning in Students With Reading Difficulties
NARecruiting
90 participants
Started: Feb 16, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor3 locations
NCT05408247
A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
PHASE4Recruiting
280 participants
Started: Feb 16, 2023 · Completed: Nov 30, 2026
1 condition2 sponsors3 locations
NCT05525663
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
NARecruiting
880 participants
Started: Feb 16, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT05157529
AQUABEAM® Robotic System and Ultrasound Accessories
NARecruiting
50 participants
Started: Feb 16, 2023 · Completed: Dec 30, 2024
2 conditions2 sponsors1 location
NCT07025200
DETACT sEvere asThmAtiC paTients - a Pilot Study
N/ARecruiting
10 participants
Started: Feb 16, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05838001
Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neoadjuvant Therapy
NARecruiting
110 participants
Started: Feb 16, 2023 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT06538974
Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population
NARecruiting
100 participants
Started: Feb 16, 2023 · Completed: Jul 2, 2027
6 conditions1 sponsor1 location
NCT05633771
Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting
N/ARecruiting
562 participants
Started: Feb 16, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor8 locations
NCT05733585
Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair
N/ARecruiting
100 participants
Started: Feb 15, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05300607
The Western Ontario Rotator Cuff Index Arabic Version
N/ARecruiting
400 participants
Started: Feb 15, 2023 · Completed: Dec 2, 2024
2 conditions1 sponsor1 location
NCT05736471
Cognitive and Affective Processes Online
N/ARecruiting
2,500 participants
Started: Feb 15, 2023 · Completed: May 2, 2026
1 condition1 sponsor1 location
NCT05739708
Psychological Characteristics of Patients With Severe Asthma
NARecruiting
150 participants
Started: Feb 15, 2023 · Completed: Feb 15, 2024
4 conditions1 sponsor1 location
NCT05746793
At High-risk for Pre-eclampsia After Assisted Reproductive Technology
N/ARecruiting
1,050 participants
Started: Feb 15, 2023 · Completed: Oct 1, 2027
1 condition1 sponsor1 location
NCT05286437
Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
PHASE2Recruiting
40 participants
Started: Feb 15, 2023 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05518188
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)
PHASE1/PHASE2Recruiting
4 participants
Started: Feb 15, 2023 · Completed: Oct 1, 2030
6 conditions2 sponsors1 location
NCT06297434
Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH
PHASE2Recruiting
80 participants
Started: Feb 15, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT04859296
AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)
PHASE1Recruiting
20 participants
Started: Feb 15, 2023 · Completed: Dec 22, 2026
3 conditions2 sponsors1 location
NCT05973539
Blood Lipid Responses to Diet
NARecruiting
60 participants
Started: Feb 15, 2023 · Completed: Jan 31, 2028
1 condition1 sponsor2 locations
NCT05809869
Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma
PHASE2Recruiting
25 participants
Started: Feb 15, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05630781
Orexin s Role in the Neurobiology of Substance Use Disorder
NARecruiting
140 participants
Started: Feb 15, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06307249
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
PHASE1Recruiting
50 participants
Started: Feb 15, 2023 · Completed: Dec 31, 2027
10 conditions2 sponsors2 locations
NCT05681962
Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy
N/ARecruiting
10,000 participants
Started: Feb 15, 2023 · Completed: Jan 31, 2026
5 conditions1 sponsor1 location
NCT05914662
Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM
PHASE2Recruiting
42 participants
Started: Feb 15, 2023 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT05139719
A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients
PHASE2Recruiting
110 participants
Started: Feb 15, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06511362
Comparative Effects of Perturbation and Functional Stabilization Training on Patellofemoral Pain Syndrome
NARecruiting
26 participants
Started: Feb 15, 2023 · Completed: Aug 25, 2024
1 condition1 sponsor1 location
NCT05868226
PRE-I-SPY Phase I/Ib Oncology Platform Program
PHASE1Recruiting
124 participants
Started: Feb 15, 2023 · Completed: Dec 30, 2029
21 conditions1 sponsor7 locations
NCT05731817
Profile of COVID-19 Patients Related to Fatigue
N/ARecruiting
398 participants
Started: Feb 15, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05717803
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)
PHASE3Recruiting
307 participants
Started: Feb 15, 2023 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT06478602
Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis
PHASE3Recruiting
30 participants
Started: Feb 15, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05714852
Promotion of Healthy Eating Behaviors in Type 2 Diabetes Patients
NARecruiting
80 participants
Started: Feb 15, 2023 · Completed: Feb 10, 2026
2 conditions1 sponsor1 location
NCT06502626
Effects of Sprint Interval Training on Field Hockey Players.
NARecruiting
28 participants
Started: Feb 15, 2023 · Completed: Aug 25, 2024
1 condition1 sponsor1 location
NCT05779787
COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)
N/ARecruiting
100 participants
Started: Feb 15, 2023 · Completed: May 15, 2027
2 conditions1 sponsor1 location
NCT04831060
Periodontitis and Inflammation
N/ARecruiting
144 participants
Started: Feb 15, 2023 · Completed: Nov 15, 2028
2 conditions1 sponsor2 locations
NCT04871048
Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia
NARecruiting
110 participants
Started: Feb 15, 2023 · Completed: Mar 1, 2026
2 conditions2 sponsors8 locations
NCT05412069
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
NARecruiting
155 participants
Started: Feb 15, 2023 · Completed: Mar 31, 2027
2 conditions2 sponsors2 locations
NCT05762601
Cellular precOnditioning for Post-Surgical Myocardial Ischemic Complications - Observational Study
N/ARecruiting
12 participants
Started: Feb 15, 2023 · Completed: Sep 30, 2025
4 conditions3 sponsors1 location
NCT05555017
Tracer-Guided Surgery for Recurrent Prostate Cancer
PHASE2Recruiting
60 participants
Started: Feb 15, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05690945
A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer
PHASE3Recruiting
608 participants
Started: Feb 15, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05694689
Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight
NARecruiting
50 participants
Started: Feb 15, 2023 · Completed: Jun 1, 2029
1 condition1 sponsor1 location